Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schomaker

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Journal of the International AIDS Society|March 5, 2020
HIV programmatic outcomes following implementation of the 'Treat-All' policy in a public sector setting in Eswatini: a prospective cohort studyBernhard Kerschberger, Michael Schomaker, Kiran Jobanputra, et al.
Tropical Medicine & International Health : TM & IH|July 17, 2019
Decreased risk of HIV-associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: a cohort and population-based analysisBernhard Kerschberger, Michael Schomaker, Alex Telnov, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2013
CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South AfricaChristopher J Hoffmann, Michael Schomaker, Matthew P Fox, et al.
Journal of the International AIDS Society|September 28, 2017
Twelve-year mortality in adults initiating antiretroviral therapy in South AfricaMorna Cornell, Leigh F Johnson, Robin Wood, et al.
German Medical Science : GMS E-Journal|February 6, 2023
Causal evidence in health decision making: methodological approaches of causal inference and health decision scienceFelicitas Kühne, Michael Schomaker, Igor Stojkov, et al.
Antiviral Therapy|February 13, 2014
Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimenRetsilisitsoe R Moholisa, Michael Schomaker, Louise Kuhn, et al.
The Lancet. HIV|October 2, 2015
Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort studyMorna Cornell, Leigh F Johnson, Michael Schomaker, et al.
Plos One|February 19, 2013
Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South AfricaMiguel Angel Luque-Fernandez, Gilles Van Cutsem, Eric Goemaere, et al.
The Pediatric Infectious Disease Journal|September 2, 2016
Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected ChildrenRetsilisitsoe R Moholisa, Michael Schomaker, Louise Kuhn, et al.
Journal of the International AIDS Society|January 15, 2022
Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort studyPatience Nyakato, Michael Schomaker, Geoffrey Fatti, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Journal of the International AIDS Society|March 5, 2020
HIV programmatic outcomes following implementation of the 'Treat-All' policy in a public sector setting in Eswatini: a prospective cohort studyBernhard Kerschberger, Michael Schomaker, Kiran Jobanputra, et al.
Tropical Medicine & International Health : TM & IH|July 17, 2019
Decreased risk of HIV-associated TB during antiretroviral therapy expansion in rural Eswatini from 2009 to 2016: a cohort and population-based analysisBernhard Kerschberger, Michael Schomaker, Alex Telnov, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2013
CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South AfricaChristopher J Hoffmann, Michael Schomaker, Matthew P Fox, et al.
Journal of the International AIDS Society|September 28, 2017
Twelve-year mortality in adults initiating antiretroviral therapy in South AfricaMorna Cornell, Leigh F Johnson, Robin Wood, et al.
German Medical Science : GMS E-Journal|February 6, 2023
Causal evidence in health decision making: methodological approaches of causal inference and health decision scienceFelicitas Kühne, Michael Schomaker, Igor Stojkov, et al.
Antiviral Therapy|February 13, 2014
Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimenRetsilisitsoe R Moholisa, Michael Schomaker, Louise Kuhn, et al.
The Lancet. HIV|October 2, 2015
Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort studyMorna Cornell, Leigh F Johnson, Michael Schomaker, et al.
Plos One|February 19, 2013
Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South AfricaMiguel Angel Luque-Fernandez, Gilles Van Cutsem, Eric Goemaere, et al.
The Pediatric Infectious Disease Journal|September 2, 2016
Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected ChildrenRetsilisitsoe R Moholisa, Michael Schomaker, Louise Kuhn, et al.
Journal of the International AIDS Society|January 15, 2022
Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort studyPatience Nyakato, Michael Schomaker, Geoffrey Fatti, et al.
Pageof 8